
Wisecube AI provides an advanced Foundational Graph AI platform designed to revolutionize life sciences R&D, particularly in drug discovery and biomedical research. Their Semantic AI Platform unifies vast biomedical datasets, offering rapid, reliable, and literature-backed answers to complex medical queries. The core of their offering is a Billion Scale Knowledge Graph, Orpheus, which synthesizes hundreds of data sources including biomedical literature, chemical and protein databases, and side effect databases. This enables customers to accelerate drug discovery and development tasks by leveraging state-of-the-art predictive AI models without needing to manage IT infrastructure. Key benefits include enhanced efficiency through streamlined drug development, adaptability to evolving data, and generalization across novel compounds. Wisecube offers products like Orpheus API, Orpheus GPT, and AI Fact-Check, aiming to improve AI trustworthiness and accuracy in research.

Wisecube AI provides an advanced Foundational Graph AI platform designed to revolutionize life sciences R&D, particularly in drug discovery and biomedical research. Their Semantic AI Platform unifies vast biomedical datasets, offering rapid, reliable, and literature-backed answers to complex medical queries. The core of their offering is a Billion Scale Knowledge Graph, Orpheus, which synthesizes hundreds of data sources including biomedical literature, chemical and protein databases, and side effect databases. This enables customers to accelerate drug discovery and development tasks by leveraging state-of-the-art predictive AI models without needing to manage IT infrastructure. Key benefits include enhanced efficiency through streamlined drug development, adaptability to evolving data, and generalization across novel compounds. Wisecube offers products like Orpheus API, Orpheus GPT, and AI Fact-Check, aiming to improve AI trustworthiness and accuracy in research.
Core product: Orpheus Foundational Graph AI / Semantic AI platform for biomedical research and drug discovery
Primary benefit: Unifies large biomedical datasets to provide literature-backed answers and accelerate R&D workflows
Founded: 2016
Headcount (reported): 5
Recent corporate event: Acquired by John Snow Labs (reported May 27, 2025)
Accelerating life-sciences R&D, drug discovery, and biomedical research intelligence.
2016
Life sciences AI / Biomedical research software
400000.00
“Founder-led funding (Vishnu Vettrivel listed as funder/lead)”